Bethesda, MD, Jan. 24, 2022 (GLOBE NEWSWIRE) -- CareMetx, a leading technology-enabled hub services company focused on improving patient access to specialty medications, and United Rheumatology, an organization representing over 660 community-based rheumatologists in 39 states, have announced today a partnership that will seek to better support patients who suffer from numerous chronic inflammatory diseases- including Rheumatoid Arthritis (RA), Psoriatic Arthritis (PSA), Ankylosing Spondylitis (AS), Lupus, and Osteoporosis.
Through this partnership, CareMetx will activate their intelligent prescription management solutions for both pharmacy and medical benefit products within United Rheumatology’s network of Providers. In addition to increased care awareness among rheumatology patients, the solution will help more effectively communicate with rheumatology patients who may need ongoing support services. A combination of these service implementations is expected to not only reduce the time it takes for rheumatology patients to begin their therapy plans, but to improve patients’ longer term ability to adhere to said care.
United Rheumatology is the preeminent rheumatology care management organization, empowering rheumatologists nationwide to advance the standard of care while leading in the development of value-based precision medicine.
The CareMetx cadre of products and services are designed to assist in this mission of elevating care standards by providing both patient and provider-centric technology and support solutions. Built with a focus on driving ongoing innovation, these technology-enabled solutions seek to lead the charge in reducing any friction that patients and providers typically face within the specialty therapy space. This vision for straightforward patient access is centered on reducing manual processes for providers, in order to allow said providers to focus specifically on patient care - not on the administrative burden that currently comes along with prescribing specialty therapies.
“There’s been a long time need for practical solutions that center the needs of the patient and allow providers to focus on communication and patient care rather than on administrative hassle and access barriers to life saving therapies” says Dr. Max Hamburger, Founder and Chairman of United Rheumatology.
“We are excited about the opportunity to offer our Providers CareMetx’s best-in-class technology platform to enroll patients into support programs that help with access to therapy and adherence,” continues Jim Albano, United Rheumatology CEO.
“Through this exciting partnership with United Rheumatology, CareMetx is able to improve patient access to life-changing therapies,” says Brock Rush, SVP & GM of CareMetx. “CareMetx has always been committed to helping patients and providers gain improved access to, and education on complex therapies, and this partnership provides us yet another opportunity to deliver on this mission.”
About CareMetx
CareMetx, LLC is a leading technology-enabled hub services platform facilitating patient access to specialty medications. Serving pharmaceutical, biotechnology and device manufacturers, CareMetx leverages digital eServices integrated in a cohesive platform to promote efficiency in the healthcare ecosystem and remove barriers for patients and providers. CareMetx is committed to delivering compassionate advocacy to patients, decision-making data and confidence-building insight to manufacturer clients. Headquartered in Bethesda, Maryland, CareMetx serves more than 80 brands. Learn more at www.caremetx.com.
About United Rheumatology
United Rheumatology represents over 660 community-based rheumatologists in 39 states. It does not own or operate rheumatology practices; the practices are all independent. A comprehensive portfolio of physician, patient, and health plan payer offerings, driven by the largest rheumatology electronic medical records clinical database in the US, supports an unparalleled platform for jointly developed coordinated care solutions. Learn more at www.unitedrheumatology.com.
